(Q33427399)

26 July 2017

title

Simultaneous determination of pioglitazone and its two active metabolites in human plasma by LC-MS/MS. (English)

1 reference

26 July 2017

Zhongping John Lin

1

1 reference

26 July 2017

Weihua Ji

series ordinal

2

1 reference

26 July 2017

Daksha Desai-Krieger

series ordinal

3

1 reference

26 July 2017

Linyee Shum

series ordinal

4

1 reference

26 July 2017

publication date

1 September 2003

1 reference

Journal of Pharmaceutical and Biomedical Analysis

26 July 2017

published in

1 reference

26 July 2017

volume

33

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

101-108

1 reference

describes a project that uses

26 July 2017

liquid chromatography–mass spectrometry

1 reference

liquid chromatography-tandem mass spectrometry

inferred from title

1 reference

Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900344-3

7 January 2021

Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900344-3

7 January 2021

Determination of pioglitazone in dog serum using solid-phase extraction and high-performance liquid chromatography with ultraviolet (229 nm) detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900344-3

7 January 2021

High-performance liquid chromatographic determination of pioglitazone and its metabolites in human serum and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900344-3

7 January 2021

Simultaneous quantitation of pioglitazone and its metabolites in human serum by liquid chromatography and solid phase extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900344-3

7 January 2021

10.1016/S0731-7085(03)00344-3

Identifiers

DOI

1 reference

26 July 2017

1 reference